Rang	Name	Position
1	Mr. Todd Foley M.B.A.	Co-Founder & Chairman
2	Dr. Matthew Roden Ph.D.	President, CEO & Director
3	Dr. Paul L. Feldman Ph.D.	Chief Scientific Officer
4	Dr. Akos Czibere M.D., Ph.D.	Chief Medical Officer
5	Dr. Patrick A. Baeuerle Ph.D.	Co-Founder & Member of Scientific Advisory Board
6	Mr. Kyle D. Kuvalanka	Chief Financial Officer
7	Dr. Shulamit Ron-Bigger Ph.D.	Chief Operating Officer
8	Dr. Tyler Benedum Ph.D.	Chief Technical Officer
9	Mr. Carlos Rodriguez	Executive Director of Corporate Development
10	Dr. Dasa Lipovsek Ph.D.	VP & Head of Lead Discovery

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	MPM Oncology Impact Management LP	8,69%	81,34 Mio. USD
2	EcoR1 Capital, LLC	8,67%	81,15 Mio. USD
3	Blue Owl Capital Holdings LP	5,52%	51,64 Mio. USD
4	BlackRock Inc	4,10%	38,32 Mio. USD
5	T. Rowe Price Investment Management,Inc.	3,69%	34,51 Mio. USD
6	Wellington Management Company LLP	3,54%	33,07 Mio. USD
7	RTW INVESTMENTS, LLC	2,86%	26,78 Mio. USD
8	HHG PLC	2,61%	24,46 Mio. USD
9	RA Capital Management, LLC	2,36%	22,11 Mio. USD
10	Jupiter Topco LLC	2,36%	22,11 Mio. USD
11	Baker Bros Advisors LP	1,79%	16,76 Mio. USD
12	Octagon Capital Advisors LP	1,73%	16,16 Mio. USD
13	Merck & Co Inc	1,71%	16,03 Mio. USD
14	Vanguard Capital Management, LLC	1,47%	13,74 Mio. USD
15	T. Rowe Price Associates, Inc.	1,37%	12,84 Mio. USD
16	TCG Crossover Management, LLC	1,25%	11,72 Mio. USD
17	Geode Capital Management, LLC	0,94%	8,76 Mio. USD
18	Eventide Asset Management, LLC	0,91%	8,53 Mio. USD
19	Avidity Partners Management LP	0,87%	8,15 Mio. USD
20	State Street Corp	0,87%	8,14 Mio. USD